Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
contracted Covid-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (contracted Covid-19) in an elderly female patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. Previously administered products included for COVID-19 prophylaxis: Spikevax NOS. Past adverse reactions to the above products included No adverse effect with Spikevax NOS. In November 2024, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced COVID-19 (contracted Covid-19). At the time of the report, COVID-19 (contracted Covid-19) outcome was unknown. The concomitant medication was not reported. Patient and her spouse both had received Spikevax in November 2024 as well as in the previous years. It was unknown if the patient experienced any additional symptoms/events. The treatment drug information was not reported. This case was linked to US-MODERNATX, INC.-MOD-2025-784855 (E2B Linked Report). Reporter did not allow further contact; Sender's Comments: US-MODERNATX, INC.-MOD-2025-784855:Patient 1 of 2